|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Less: Net loss from discontinued operations | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Amortization and depreciation | |||||
| Common stock and stock option based compensation for employees and board of directors | |||||
| Net gain on divestiture of subsidiaries | |||||
| Reserve on note received in connection with divestiture of subsidiary | |||||
| Reserve on notes received in connection with divestiture of subsidiaries | |||||
| Gain on office lease termination | |||||
| Accrued non cash performance bonus fair value adjustment | |||||
| Stock option based compensation for employees and board of directors | |||||
| Acquisition contingent consideration fair value adjustment | |||||
| Impairment of intangible assets | |||||
| Issuance of common stock to vendors | |||||
| Goodwill impairment | |||||
| Adjustment to operating lease right-of-use assets and liabilities | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Deferred costs/contract assets | |||||
| Deferred costs | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue/contract liabilities | |||||
| Deferred revenue | |||||
| Net cash (used in) provided by operating activities from continuing operations | |||||
| Net cash used in operating activities from discontinued operations | |||||
| Net cash used in operating activities | |||||
| Cash flow from investing activities: | |||||
| Purchase of equipment | |||||
| Payment of contingent consideration for acquisition | |||||
| Cash used in investing activities from continuing operations | |||||
| Cash provided (used) by investing activities from discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows provided by financing activities: | |||||
| Notes receivable repayments (issuance), net | |||||
| Proceeds from securities purchase agreement, net | |||||
| Proceeds from exercise of warrants | |||||
| Issuance of notes receivable | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents - continuing operations, beginning of period | |||||
| Cash and cash equivalents - discontinued operations, beginning of period | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Issuance of common stock for satisfaction of contingent liability | |||||
| Issuance of common stock for non cash performance bonus | |||||
| Lease liabilities arising from right-of-use assets | |||||
Loading...